GeneQuantum and MITRO Enter into Strategic Cooperation to Develop Next Generation Radionuclide…
On February 1, 2019, GeneQuantum Healthcare of Suzhou and MITRO Biotech of Nanjing signed the "Strategic Cooperation Agreement on Next Generation Radionuclide Conjugates Development" in…
Read More...
Read More...
